Clinical Trial Update: A Study of Linvo-VR vs DVRd in Transplant-Eligible Adult Participants With Newly Diagnosed Multiple Myeloma (NDMM) [Phase 2, Phase 3]

View source ↗

Summary

A Phase 2/3 clinical trial update announcing a study comparing Linvo-VR against the DVRd regimen in transplant-eligible adults with newly diagnosed multiple mye…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Multiple Myeloma

Drugs mentioned

• Bortezomib (bortezomib)
• DEXAMETHASONE (Dexamethasone)
• Daratumumab (daratumumab)
• Lenalidomide (lenalidomide)
• Linvo-VR

Snippet

Sponsor: Regeneron Pharmaceuticals | Conditions: Multiple Myeloma (MM) | Phase 2, Phase 3 | Status: NOT_YET_RECRUITING